Autonomix Medical Inc (AMIX) Stock Price, Quote & News

Company Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related diso...

Industry: Medical Devices

Sector: Healthcare

Phone: 713 588 6150

Website: autonomix.com

Address:

21 Waterway Avenue, Suite 300, The Woodlands, United States

focafoca99 Apr. 29 at 2:14 PM

$AMIX announced abstract acceptance at Digestive Disease Week 2026 featuring long-term data in pancreatic cancer pain mitigation.

0 · Reply

VinWeezel Apr. 29 at 12:53 PM

$AMIX https://www.stocktitan.net/news/AMIX/autonomix-medical-announces-abstract-acceptance-at-digestive-disease-0b5roe0l5clo.html

1 · Reply

PrimeZoneNews Apr. 28 at 5:37 PM

$AMIX has been granted U.S. patent today, titled "Devices, systems, and methods for diagnosis and treatment of overactive bladder". Watch before close!😉

0 · Reply

RISE07 Apr. 24 at 10:56 PM

$AMIX Hoping it will reach $1.00 Before July 13

1 · Reply

coolmate25 Apr. 23 at 7:36 PM

$AMIX Yet another small news lol ! Wish they get some investment before big news.

0 · Reply

coolmate25 Apr. 22 at 7:40 PM

$AMIX All that news still not enough, we really need that De-novo Clarence.

0 · Reply

focafoca99 Apr. 22 at 6:41 PM

$AMIX will present long-term pancreatic cancer pain mitigation data at ECIO 2026.

0 · Reply

coolmate25 Apr. 22 at 2:33 PM

$AMIX Don't know what the fck is going on today ? Hoping for late pickup .

0 · Reply

dwhall5056 Apr. 22 at 1:08 PM

$AMIX Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 ... https://ir.autonomix.com/autonomix-medical-to-present-long-term-pain-mitigation-data-in-pancreatic-cancer-at-ecio-2026/

1 · Reply

VinWeezel Apr. 22 at 12:36 PM

$AMIX yikes?

0 · Reply

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Apr 22, 2026, 8:42 AM EDT - 7 days ago

Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026

Apr 8, 2026, 8:40 AM EDT - 21 days ago

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

Mar 11, 2026, 8:40 AM EDT - 7 weeks ago

Autonomix Medical to Present at LSI USA '26

Mar 5, 2026, 8:45 AM EST - 7 weeks ago

Autonomix Medical Selected for Best Innovation Competition at CRT 2026

Mar 4, 2026, 8:40 AM EST - 2 months ago

Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis

Feb 25, 2026, 8:30 AM EST - 2 months ago

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation

Feb 19, 2026, 8:30 AM EST - 2 months ago

Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation

Jan 9, 2026, 8:45 AM EST - 3 months ago

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

Dec 23, 2025, 8:45 AM EST - 4 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

Dec 18, 2025, 8:30 AM EST - 4 months ago

Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

Nov 26, 2025, 8:45 AM EST - 5 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

Oct 24, 2025, 9:00 AM EDT - 6 months ago

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Oct 16, 2025, 9:15 AM EDT - 6 months ago

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Oct 9, 2025, 8:45 AM EDT - 7 months ago

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Oct 2, 2025, 8:45 AM EDT - 7 months ago

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Sep 29, 2025, 9:15 AM EDT - 7 months ago

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Sep 4, 2025, 9:00 AM EDT - 8 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Sep 3, 2025, 8:30 AM EDT - 8 months ago

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Sep 2, 2025, 8:30 AM EDT - 8 months ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Aug 18, 2025, 9:15 AM EDT - 9 months ago

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Aug 15, 2025, 9:00 AM EDT - 9 months ago

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 14, 2025, 8:30 AM EDT - 9 months ago

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Jul 22, 2025, 8:45 AM EDT - 10 months ago

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 21, 2025, 8:45 AM EDT - 10 months ago

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Jun 30, 2025, 8:30 AM EDT - 10 months ago

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Jun 27, 2025, 8:00 AM EDT - 10 months ago

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 5, 2025, 8:45 AM EDT - 11 months ago

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

May 15, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

May 14, 2025, 9:20 AM EDT - 1 year ago

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

May 13, 2025, 9:20 AM EDT - 1 year ago

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

May 5, 2025, 8:30 AM EDT - 1 year ago

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

May 1, 2025, 9:25 AM EDT - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

Apr 30, 2025, 8:15 AM EDT - 1 year ago

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Apr 24, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Apr 17, 2025, 5:00 PM EDT - 1 year ago

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Apr 8, 2025, 8:15 AM EDT - 1 year ago

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Apr 3, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Mar 14, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Feb 20, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Feb 13, 2025, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Jan 24, 2025, 8:45 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Jan 17, 2025, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Jan 15, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Jan 13, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Dec 30, 2024, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Dec 5, 2024, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Nov 25, 2024, 4:00 PM EST - 1 year ago

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

focafoca99 Apr. 29 at 2:14 PM

$AMIX announced abstract acceptance at Digestive Disease Week 2026 featuring long-term data in pancreatic cancer pain mitigation.

0 · Reply

VinWeezel Apr. 29 at 12:53 PM

$AMIX https://www.stocktitan.net/news/AMIX/autonomix-medical-announces-abstract-acceptance-at-digestive-disease-0b5roe0l5clo.html

1 · Reply

PrimeZoneNews Apr. 28 at 5:37 PM

$AMIX has been granted U.S. patent today, titled "Devices, systems, and methods for diagnosis and treatment of overactive bladder". Watch before close!😉

0 · Reply

RISE07 Apr. 24 at 10:56 PM

$AMIX Hoping it will reach $1.00 Before July 13

1 · Reply

coolmate25 Apr. 23 at 7:36 PM

$AMIX Yet another small news lol ! Wish they get some investment before big news.

0 · Reply

coolmate25 Apr. 22 at 7:40 PM

$AMIX All that news still not enough, we really need that De-novo Clarence.

0 · Reply

focafoca99 Apr. 22 at 6:41 PM

$AMIX will present long-term pancreatic cancer pain mitigation data at ECIO 2026.

0 · Reply

coolmate25 Apr. 22 at 2:33 PM

$AMIX Don't know what the fck is going on today ? Hoping for late pickup .

0 · Reply

dwhall5056 Apr. 22 at 1:08 PM

1 · Reply

VinWeezel Apr. 22 at 12:36 PM

$AMIX yikes?

0 · Reply

coolmate25 Apr. 14 at 5:15 PM

$AMIX Same old sh-t every single day , seems like there is someone keep pumping dumping on low level , with their low level mentality.

1 · Reply

dwhall5056 Apr. 14 at 2:47 PM

$AMIX face it, this stock has been good for bearish scalpers for a while now. Sure hoping for the kind of news that will give it a good bullish trajectory soon.

0 · Reply

coolmate25 Apr. 13 at 6:17 PM

$AMIX A little bit going up ? That's me buying lol and low life pos living in dumpsters taking it lol 😆.

0 · Reply

coolmate25 Apr. 10 at 8:05 PM

$AMIX I bought more today but there are some low life SOBs that has parasitic DNA keep fckn it up. Soon the shorts squeeze will bury their souls forever . Amin

0 · Reply

coolmate25 Apr. 9 at 3:16 PM

$AMIX According to Robinhood, the borrow rate is kinda high with less short flow and some elevated short interest so this upcoming news can well (if early) can hit the stock high. Imo so what are your options?

0 · Reply

coolmate25 Apr. 9 at 3:09 PM

$AMIX Just waiting for that May news of De-Novo application to fda that they promised a year ago so I wish we get some more investors till then .

0 · Reply

coolmate25 Apr. 8 at 5:54 PM

$AMIX See that's the problem with this stock since most of the people here are just day traders and some low life greedy SOB hourly traders , they don't let it breath . We really need some good professionals that can hold it for a while since this stock totally depends on investments .

1 · Reply

coolmate25 Apr. 8 at 3:12 PM

$AMIX

0 · Reply

coolmate25 Apr. 8 at 3:02 PM

$AMIX

0 · Reply

dwhall5056 Apr. 8 at 1:18 PM

$AMIX Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 ... https://ir.autonomix.com/autonomix-medical-selected-for-featured-abstract-and-podium-presentation-of-long-term-pain-mitigation-in-pancreatic-cancer-at-sir-2026/

0 · Reply

coolmate25 Apr. 8 at 2:13 AM

$AMIX The next big upcoming news will be if they apply for De Novo application , they said in May I guess .

0 · Reply

SuperGreenToday Apr. 7 at 12:17 AM

$AMIX

0 · Reply

Market Cap	2.55M
Revenue (ttm)	0.00
Net Income (ttm)	-11.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	338,744
Avg Vol	139,466
Day's Range	N/A - N/A
Shares Out	6.91M
Stochastic %K	43%
Beta	-2.48
Analysts	Strong Sell
Price Target	$2.00